ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
2027 ANS Winter Conference and Expo
October 31–November 4, 2027
Washington, DC|The Westin Washington, DC Downtown
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2024
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
December 2024
Nuclear Technology
Fusion Science and Technology
November 2024
Latest News
Argonne investigates industrial SMR applications for postwar Ukraine
Argonne National Laboratory will play a leading role in planning and rebuilding a nuclear-generated clean energy infrastructure for postwar Ukraine as part of the lab’s focus on developing small modular reactor applications to help countries meet energy security goals. The latest plans, described in a November 19 article, were announced on November 16 at COP29 in Baku, Azerbaijan.
A. Trivedi, R.B. Richardson, D. Galeriu
Fusion Science and Technology | Volume 28 | Number 3 | October 1995 | Pages 982-987
Tritium Safety | Proceedings of the Fifth Topical Meeting on Tritium Technology in Fission, Fusion, and Isotopic Applications Belgirate, Italy May 28-June 3, 1995 | doi.org/10.13182/FST95-A30533
Articles are hosted by Taylor and Francis Online.
Tritiated watero (HTO) represents the mosl important occupational and environmental exposures to tritium, as far as radiation protection is concerned We have studied the dynamics of HTO and organically bound tritium* (OBT) in urine, feces and blood from male workers at 100–300 d following an acute intake of HTO. Blood and cumulative 24 h urine and fecal samples were collected and analyzed for HTO and OBT. The activity concentrations oi HTO in urine and HTO in feces were in equilibrium and were representative of HTO in the body water (HTO in blood). The ratio of bound tritium per gram hydrogen (Bq·H−1) in organic matter in feces (OBTfeces) to urine (OBTurine) was 1.0 ± 0.1. Similarly, the ratios of OBTblood to OBTurine and OBTblood to OBTfeces were 0.9 ± 0.2 and 1.1 ± 0.2, respectively. These results suggest that, providing an equilibrium condition exists, a measurement of the tritium activity per unit mass of organic matter in urine or feces can provide an assessment of the specific activity of tritium in the organic fraction ol the soft tissue. The activity concentrations of HTO and OBT in urine samples, from a few days up to 300 d post-exposure, were examined for the clearance kinetics of HTO in urine and OBT in urine. The early presence of OBT in urine indicated that a portion of tritium from the ingested HTO is rapidly fixed into organic constituents of the body. The half-life for the longer-term component of OBT in urine is comparable to the half-life for the longer-term component of HTO in urine. This close relationship between the longer-term excretion of HTO in urine and OBT in urine suggests that most of the HTO produced in its longer-term component is a by-product of metabolized OBT. This work has demonstrated that OBT is excreted in urine in all examinations, up to 300 d post-exposure to HTO, and that a fraction of the metabolized OBT is also excreted in feces.
